Trade Summary

4 days ago, Thompson Rahsaan, serving as Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 34,557 shares at $12.68 per share, for a total transaction value of $438,303.71. Following this transaction, Thompson Rahsaan now holds 80,235 shares of ZVRA.

This sale represents a 30.10% decrease in Thompson Rahsaan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 23, 2026 at 4:16 PM ET, 1 day after the trade was made.

ZEVRA THERAPEUTICS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.